Patients with PKD2 mutations have milder kidney disease with less kidney cysts, later onset of hypertension and kidney failure, and improved survival than is seen in patients with PKD1 mutations. Identical renal and extrarenal manifestations are, however, seen in patients with PKD1 and PDK2 mutations.
PKD1 mutations account for the majority of ADPKD patients seen in renal clinics (approximately 85%), with PKD2 mutations responsible for the remainder of patients (approximately 15%).
Learn more about pathophysiology in ADPKD.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Neera K. Dahl. Fast Five Quiz: Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Medscape - Aug 06, 2021.